Clinical trial
Network Osteoporosis Study
NCT00209469 · Glaser Pediatric Research Network, Other · Unknown status
Key facts
| NCT number | NCT00209469 |
|---|---|
| Title | Network Osteoporosis Study |
| Official title | Double Blind Controlled Trial of Alendronate for the Treatment of Childhood and Adolescent Glucocorticoid-Associated Osteopenia and Osteoporosis |
| Lead sponsor | Glaser Pediatric Research Network, Other |
| Collaborators | Elizabeth Glaser Pediatric AIDS Foundation |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Osteopenia, Osteoporosis |
| Intervention type | Drug |
| Interventions | alendronate sodium |
| Enrollment | 90 |
| Start date | Jul 1, 2002 |
| Completion | Feb 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Sep 21, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: